Your browser doesn't support javascript.
loading
Endothelin-1 (ET-1) contributes to senescence and phenotypic changes in brain pericytes in diabetes-mimicking conditions.
Edgerton-Fulton, Mia; Abdul, Yasir; Jamil, Sarah; Ergul, Adviye.
Afiliación
  • Edgerton-Fulton M; Department of Pathology & Laboratory Medicine, Medical University of South Carolina, Charleston, SC, U.S.A.
  • Abdul Y; Department of Pathology & Laboratory Medicine, Medical University of South Carolina, Charleston, SC, U.S.A.
  • Jamil S; Department of Pathology & Laboratory Medicine, Medical University of South Carolina, Charleston, SC, U.S.A.
  • Ergul A; Department of Pathology & Laboratory Medicine, Medical University of South Carolina, Charleston, SC, U.S.A.
Clin Sci (Lond) ; 138(16): 1009-1022, 2024 Aug 21.
Article en En | MEDLINE | ID: mdl-39106080
ABSTRACT
Diabetes mediates endothelial dysfunction and increases the risk of Alzheimer's disease and related dementias. Diabetes also dysregulates the ET system. ET-1-mediated constriction of brain microvascular pericytes (BMVPCs) has been shown to contribute to brain hypoperfusion. Cellular senescence, a process that arrests the proliferation of harmful cells and instigates phenotypical changes and proinflammatory responses in endothelial cells that impact their survival and function. Thus, we hypothesized that ET-1 mediates BMVPC senescence and phenotypical changes in diabetes-like conditions. Human BMVPCs were incubated in diabetes-like conditions with or without ET-1 (1 µmol/L) for 3 and 7 days. Hydrogen peroxide (100 µmol/L H2O2) was used as a positive control for senescence and to mimic ischemic conditions. Cells were stained for senescence-associated ß-galactosidase or processed for immunoblotting and quantitative real-time PCR analyses. In additional experiments, cells were stimulated with ET-1 in the presence or absence of ETA receptor antagonist BQ-123 (20 µmol/L) or ETB receptor antagonist BQ-788 (20 µmol/L). ET-1 stimulation increased ß-galactosidase accumulation which was prevented by BQ-123. ET-1 also increased traditional senescence marker p16 protein and pericyte-specific senescence markers, TGFB1i1, PP1CA, and IGFBP7. Furthermore, ET-1 stimulated contractile protein α-SMA and microglial marker ostepontin in high glucose suggesting a shift toward an ensheathing or microglia-like phenotype. In conclusion, ET-1 triggers senescence, alters ETA and ETB receptors, and causes phenotypical changes in BMVPCs under diabetes-like conditions. These in vitro findings need to be further studied in vivo to establish the role of ETA receptors in the progression of pericyte senescence and phenotypical changes in VCID.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Senescencia Celular / Endotelina-1 / Pericitos / Receptor de Endotelina A Límite: Humans Idioma: En Revista: Clin Sci (Lond) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Senescencia Celular / Endotelina-1 / Pericitos / Receptor de Endotelina A Límite: Humans Idioma: En Revista: Clin Sci (Lond) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido